A four-week course of glecaprevir/pibrentasvir achieved sustained virologic response in 84% of patients with early hepatitis C infection in the PURGE-C trial, suggesting potential for shorter, more accessible treatment regimens pending further validation.
https://t.co/zjyYVqaXHt
Polling #oncopharm what anti-fungal prophylaxis strategy does your institution utilize in AML induction (intensive and non-intensive)?
Do you avoid azoles or make dose reductions on days venetoclax is given?
Would love to hear what other centers are doing!
🆕️⚡️ @AJHPOfficial
Cost evaluation of continuation of therapy with dalbavancin compared to standard-of-care antibiotics alone in hospitalized persons who inject drugs with severe gram-positive infections #IDXposts#PWID
https://t.co/qzvqfCRz7s
🆕️⚡️ @AJHPOfficial
Cost evaluation of continuation of therapy with dalbavancin compared to standard-of-care antibiotics alone in hospitalized persons who inject drugs with severe gram-positive infections #IDXposts#PWID
https://t.co/qzvqfCRz7s
Poster 625 at #SHEASpring2023: Do you have FOMO (fear of missing organisms)? If your patient with a diabetic foot infection has not had a culture with Pseudomonas in the past year, this has a negative predictive value of 94%. Hold on the pip-tazo!
Amoxicillin is amazing drug — don’t be afraid to push the dose to 1000 mg PO q6h- 100% target attainment for Streptococci. Check out this extremely cool paper recently published and shared by Dr. Jim Lewis at #SHEASpring2023@SHEA_Epi https://t.co/FDC0EkMs6M
🚨 New Post 🚨
Here are my TOP 🔟 journal articles for infectious diseases pharmacy rotations
🤔 Have fun one not listed? Share the link and let us know why you 😁love it!
#IDtwitter#Medtwitter#TwitteRx
📲 https://t.co/B3HS1ziEqx
🆕️⚡️ @antibioticsmdpi
Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of CDI
Despite higher fidaxomicin drug costs, overall cost savings were estimated at GBP 140,292 (GBP 2125 per CDI #IDTwitter
https://t.co/QKnKXRAYil
Hot take: the amount of Louis Vuitton and YSL bags I’ve seen at midyear is a blatant reminder that being here is a privilege. To the RPDs out there, please don’t discount applicants that couldn’t afford to be here with us.
Congrats to our previous PGY-2 ID residents, @ashinetobacter and @AlysaMartinRX , for the recent publication of their flipped-model research project evaluating clinical outcomes of nCP-CRE compared with carbapenem-susceptible Enterobacterales infections
https://t.co/H0yKTQpPkx